M

Mindset Pharma Inc
CNSX:MSET

Watchlist Manager
Mindset Pharma Inc
CNSX:MSET
Watchlist
Price: 0.6 CAD 5.26% Market Closed
Market Cap: CA$60.8m

Net Margin

-90.9%
Current
Declining
by 14.7%
vs 3-y average of -76.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-90.9%
=
Net Income
CA$-5.6m
/
Revenue
CA$6.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-90.9%
=
Net Income
CA$-5.6m
/
Revenue
CA$6.1m

Peer Comparison

Country Company Market Cap Net
Margin
CA
Mindset Pharma Inc
CNSX:MSET
60.8m CAD
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Lower than 70% of companies in Canada
Percentile
30th
Based on 4 909 companies
30th percentile
-90.9%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Mindset Pharma Inc
Glance View

Market Cap
60.8m CAD
Industry
Pharmaceuticals

Mindset Pharma, Inc. is a pharmaceutical discovery and development company. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-12-23. The firm is focused on developing patentable psychedelic compounds for the treatment of neurological and psychiatric disorders, with an initial focus on psilocybin-inspired new chemical entities (NCEs). Its drug development platform seeks to advance medicines based on psychedelic substances through rigorous scientific and clinical trials, performed by third-party contract research organizations. The firm intends to commercialize the psilocybin-inspired psychedelic medicines that it develops as regulated medicines.

MSET Intrinsic Value
Not Available
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-90.9%
=
Net Income
CA$-5.6m
/
Revenue
CA$6.1m
What is Mindset Pharma Inc's current Net Margin?

The current Net Margin for Mindset Pharma Inc is -90.9%, which is below its 3-year median of -76.2%.

How has Net Margin changed over time?

Over the last 1 years, Mindset Pharma Inc’s Net Margin has increased from -922% to -90.9%. During this period, it reached a low of -922% on Mar 31, 2022 and a high of -61.5% on Dec 31, 2022.

Back to Top